Radiation therapy firm North American Scientific (NAS) of Chatsworth, CA, reported revenue growth in the company's third-quarter financial results.
For the period (end-July 31), NAS posted revenue from continuing operations of $3.4 million, up 26% from $2.7 million in sales in the same period the year before. The company's net loss from continuing operations for the period was $4.1 million, compared with a net loss of $3 million in the same quarter a year ago.
The continuing operations numbers exclude the results of the company's Nomos and nontherapeutic product lines, which have been divested.
Related Reading
NAS completes nontherapeutic product sell-off, September 8, 2008
NAS to divest nontherapeutic products, September 4, 2008
NAS gets Nasdaq noncompliance notice, August 25, 2008
NAS taps new VP of marketing, July 15, 2008
NAS fails to meet Nasdaq minimum bid price, April 11, 2008
Copyright © 2008 AuntMinnie.com
